Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease | Citedby Results | Digestive Diseases | Karger Publishers

Skip to Main Content

Skip Nav Destination

Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease

Dig Dis (2023) 41 (3): 439–446.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis

Alicja Bauer
Tomasz Rawa

International Journal of Molecular Sciences (2024) 25 (2): 1333.

Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning

Zheng Luo
Cong Huang
Jilan Chen
Yunhui Chen
Hongya Yang
Qiaofeng Wu
Fating Lu
Tian E. Zhang

Frontiers in Medicine (2024) 11

Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis

Limin Cao
Yu An
Huiyuan Liu
Jinguo Jiang
Wenqi Liu
Yuhan Zhou
Mengyuan Shi
Wei Dai
Yanling Lv
Yuhong Zhao
Yanhui Lu
Liangkai Chen
Yang Xia

BMC Medicine (2024) 22 (1)

Uncovering the Silent Killer: Research Highlights on Chronic Liver Diseases

Yao-Chun Hsu

Digestive Diseases (2023) 41 (4): 645.